As of June 3, 2025, Spineway SA (ALSPW.PA) reports a ROA (Return on Assets) of -24.74%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Spineway SA's ROA (Return on Assets)
Over recent years, Spineway SA's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2023-12-31 | -24.74% |
| 2022-12-31 | -11.33% |
| 2021-12-31 | -6.19% |
| 2020-12-31 | -95.26% |
| 2019-12-31 | -22.52% |
This slight downward trend highlights how Spineway SA manages its efficiency in using assets to generate earnings over time.
Comparing Spineway SA's ROA (Return on Assets) to Peers
To better understand Spineway SA's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Spineway SA (ALSPW.PA) | -24.74% |
| Biohit Oyj (BIOBV.HE) | 16.57% |
| Arcoma AB (ARCOMA.ST) | 13.89% |
| Biomerieux SA (BIM.PA) | 7.49% |
| Klea Holding (ALVMG.PA) | 2.46% |
| Amplitude Surgical SA (AMPLI.PA) | 0.55% |
Compared to its competitors, Spineway SA's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.